Why the Ecofibre (ASX:EOF) share price is soaring 9% higher today

The Ecofibre Ltd (ASX: EOF) share price is soaring 9% higher during mid-morning trade after providing an interim investor update. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ecofibre Ltd (ASX: EOF) share price is on the move during mid-morning trade after providing an interim investor update.

At the time of writing, the hemp company's shares are swapping hands for as much as 86.5 cents apiece, up 9.4%.

What did Ecofibre announce?

Investors are fighting to get a hold of Ecofibre shares following the company's strong recovery of business growth.

In a statement to the ASX, Ecofibre revealed improved momentum in its core United States independent pharmacy business. In April alone, the Ananda Professional pharmacy segment saw its best month since September 2020.

As a result, the company reaffirmed its profit guidance released in February for the FY21 period.

Ecofibre expects profit to come at a loss of $1.5 million for the second half of the year. This will contribute to an overall forecasted loss of around $7 million for FY21.

Pleasingly, the H2 FY21 profit is looking to include roughly US$1.8 million from employee retention credits. The funds to be received fall under former President Trump's 'Taxpayer Certainty and Disaster Tax Relief Act of 2020'. This was a coronavirus relief and spending bill to assist businesses that were forced to close during the government-mandated lockdown.

Ecofibre CEO, Eric Wang touched on the company's progress saying:

Since the middle of March, we have seen a good return to growth in our core independent pharmacy channel as COVID related disruptions subside.

We see trading conditions improving for our core independent pharmacy channel as the US moves into post-COVID environment. We look forward to Ananda Health revenues returning to pre-COVID levels in due course.

Ecofibre share price snapshot

While today's positive announcement lifted Ecofibre shares, yearly performance has not been so kind to investors. The company's share price has fallen more than 70% from the past 12 months and is down almost 60% year-to-date.

Ecofibre has a market capitalisation of approximately $271 million, with about 339.3 million shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Two kids play joyfully in the crashing waves.
Healthcare Shares

2 ASX healthcare shares making splashes in the US

These two names could see significant growth in the United States.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX biotech shares rocketing more than 40% on big news

These two ASX healthcare companies have exciting news for investors today.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Telix Pharmaceuticals share price sinks 5% on giant debt deal

This high-growth drug developer is turning to debt for its next wave of expansion.

Read more »

Lab worker puts hands in the air and dances around
Healthcare Shares

Guess which ASX healthcare stock just rocketed 46% on major news!

Investors are sending this ASX healthcare stock flying higher on Wednesday. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Earnings Results

Polynovo share price surges after 57% revenue gain in FY24

Global sales continue to grow for Polynovo.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Healthcare Shares

If you invested $5,000 in this ASX pharmaceuticals stock a year ago, you'd have $34,711 now!

Just how lucky have investors been with this stock?

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Healthcare Shares

Should I buy CSL shares now for their 'steadily growing' dividends?

CSL has increased its interim and final dividend payouts for four years running now.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Guess which ASX healthcare stock is surging on big FDA news

The update is a critical milestone for the company.

Read more »